TrialCancer chemotherapy and pharmacology2021

Phase I/II study to assess the clinical pharmacology and safety of single ascending and multiple subcutaneous doses of PF-06881894 in women with non-distantly metastatic breast cancer.

Hsuan-Ming Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.